These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

293 related articles for article (PubMed ID: 31816725)

  • 21. Method development and validation for the quantification of dasatinib, erlotinib, gefitinib, imatinib, lapatinib, nilotinib, sorafenib and sunitinib in human plasma by liquid chromatography coupled with tandem mass spectrometry.
    Lankheet NA; Hillebrand MJ; Rosing H; Schellens JH; Beijnen JH; Huitema AD
    Biomed Chromatogr; 2013 Apr; 27(4):466-76. PubMed ID: 22987603
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Development of a Sensitive and High-Throughput Assay for Simultaneous Quantification of 5 Tyrosine Kinase Inhibitors and 2 Active Metabolites in Human Plasma Using Ultra-high Performance Liquid Chromatography Coupled to Tandem Mass Spectrometry.
    Sumimoto T; Nakahara R; Suzuki Y; Tanaka R; Yoshida N; Ogata M; Itoh H
    Ther Drug Monit; 2022 Jun; 44(3):419-429. PubMed ID: 34469417
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A liquid chromatography-tandem mass spectrometry method for simultaneous quantification of thirty-nine tyrosine kinase inhibitors in human plasma.
    Guo ZX; Wu YE; Shi HY; van den Anker J; Liang P; Zheng Y; Zhao XW; Feng R; Zhao W
    J Pharm Biomed Anal; 2023 Feb; 224():115159. PubMed ID: 36442459
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Simultaneous quantitative determination of seven novel tyrosine kinase inhibitors in plasma by a validated UPLC-MS/MS method and its application to human microsomal metabolic stability study.
    Ezzeldin E; Iqbal M; Herqash RN; ElNahhas T
    J Chromatogr B Analyt Technol Biomed Life Sci; 2020 Jan; 1136():121851. PubMed ID: 31812004
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Quantification of 11 Therapeutic Kinase Inhibitors in Human Plasma for Therapeutic Drug Monitoring Using Liquid Chromatography Coupled With Tandem Mass Spectrometry.
    Herbrink M; de Vries N; Rosing H; Huitema AD; Nuijen B; Schellens JH; Beijnen JH
    Ther Drug Monit; 2016 Dec; 38(6):649-656. PubMed ID: 27749781
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Development and validation of a multiplex HPLC-MS/MS assay for the monitoring of JAK inhibitors in patient plasma.
    Tachet J; Versace F; Mercier T; Buclin T; Decosterd LA; Choong E; Girardin FR
    J Chromatogr B Analyt Technol Biomed Life Sci; 2023 Nov; 1230():123917. PubMed ID: 37956468
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Volumetric absorptive microsampling as a suitable tool to monitor tyrosine kinase inhibitors.
    Verougstraete N; Stove CP
    J Pharm Biomed Anal; 2022 Jan; 207():114418. PubMed ID: 34655987
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Simultaneous determination of nine tyrosine kinase inhibitors by 96-well solid-phase extraction and ultra performance LC/MS-MS.
    Bouchet S; Chauzit E; Ducint D; Castaing N; Canal-Raffin M; Moore N; Titier K; Molimard M
    Clin Chim Acta; 2011 May; 412(11-12):1060-7. PubMed ID: 21345336
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Simultaneous quantification of dasatinib, nilotinib, bosutinib, and ponatinib using high-performance liquid chromatography-Photodiode array detection.
    Yokoyama Y; Nozawa E; Morita M; Ishikawa E; Mori T; Sakurai M; Kikuchi T; Matsuki E; Yamazaki R; Kataoka K; Jibiki A; Kawazoe H; Suzuki S; Nakamura T
    J Clin Lab Anal; 2022 Aug; 36(8):e24598. PubMed ID: 35819095
    [TBL] [Abstract][Full Text] [Related]  

  • 30. High throughput routine determination of 17 tyrosine kinase inhibitors by LC-MS/MS.
    Merienne C; Rousset M; Ducint D; Castaing N; Titier K; Molimard M; Bouchet S
    J Pharm Biomed Anal; 2018 Feb; 150():112-120. PubMed ID: 29220734
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Routine therapeutic drug monitoring of tyrosine kinase inhibitors by HPLC-UV or LC-MS/MS methods.
    Miura M; Takahashi N
    Drug Metab Pharmacokinet; 2016 Feb; 31(1):12-20. PubMed ID: 26732608
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Development and clinical application of a LC-MS/MS method for simultaneous determination of various tyrosine kinase inhibitors in human plasma.
    Götze L; Hegele A; Metzelder SK; Renz H; Nockher WA
    Clin Chim Acta; 2012 Jan; 413(1-2):143-9. PubMed ID: 21945732
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Simultaneous online SPE-HPLC-MS/MS quantification of gefitinib, osimertinib and icotinib in dried plasma spots: Application to therapeutic drug monitoring in patients with non-small cell lung cancer.
    Jia M; Wu Z; Shi W; Wang S; Huang X; Zhang M; Bao W; Bao A; Zhang P; Ding F; Xie G; Lou Y; Fan G
    J Pharm Biomed Anal; 2023 May; 228():115275. PubMed ID: 36871365
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Further Analytical, Pharmacokinetic, and Clinical Observations on Low-Dose Ponatinib in Patients with Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia.
    Menna P; De Grazia U; Marchesi F; Minotti G; Salvatorelli E
    Chemotherapy; 2020; 65(1-2):35-41. PubMed ID: 32829325
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A validated UPLC-MS/MS method for simultaneous determination of imatinib, dasatinib and nilotinib in human plasma.
    Zeng J; Cai HL; Jiang ZP; Wang Q; Zhu Y; Xu P; Zhao XL
    J Pharm Anal; 2017 Dec; 7(6):374-380. PubMed ID: 29404062
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A validated assay for the simultaneous quantification of six tyrosine kinase inhibitors and two active metabolites in human serum using liquid chromatography coupled with tandem mass spectrometry.
    van Erp NP; de Wit D; Guchelaar HJ; Gelderblom H; Hessing TJ; Hartigh Jd
    J Chromatogr B Analyt Technol Biomed Life Sci; 2013 Oct; 937():33-43. PubMed ID: 24013127
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Simultaneous measurement of imatinib, nilotinib and dasatinib in dried blood spot by ultra high performance liquid chromatography tandem mass spectrometry.
    Kralj E; Trontelj J; Pajič T; Kristl A
    J Chromatogr B Analyt Technol Biomed Life Sci; 2012 Aug; 903():150-6. PubMed ID: 22857863
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Isocyanate derivatization coupled with phospholipid removal microelution-solid phase extraction for the simultaneous quantification of (S)-metoprolol and (S)-α-hydroxymetoprolol in human plasma with LC-MS/MS.
    Meloche M; Jutras M; St-Jean I; de Denus S; Leclair G
    J Pharm Biomed Anal; 2021 Sep; 204():114263. PubMed ID: 34274593
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A high-throughput method for the determination of 14 UV-filters in human plasma by LC-MS/MS: Minimize interferences from proteins and phospholipids in the matrix.
    Yang W; Feng J; Liang W; Nie M; Tan J; Fan R
    J Chromatogr B Analyt Technol Biomed Life Sci; 2024 Apr; 1237():124090. PubMed ID: 38522130
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Simultaneous determination of methotrexate, dasatinib and its active metabolite N- deshydroxyethyl dasatinib in rat plasma by LC-MS/MS: method validation and application to pharmacokinetic study.
    Thappali SR; Varanasi KV; Veeraraghavan S; Vakkalanka SK; Khagga M
    Arzneimittelforschung; 2012 Dec; 62(12):624-30. PubMed ID: 23138519
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.